{"date":"2025-06-02","count":9,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6762-2025-06-02-1821-1r8f1c2","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-06-02","time":"18:21:43","subject":"公告本公司董事會授權董事長訂定除息、除權暨增資基準日及相關事宜。","clause":"第53款","fact_date":"2025-05-26","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-06-02 18:21，「公告本公司董事會授權董事長訂定除息、除權暨增資基準日及相關事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2025-06-02-1817-5rax5d","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2025-06-02","time":"18:17:20","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第9款","fact_date":"2025-06-02","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2025-06-02 18:17，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-06-02-1750-1o04w1","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-06-02","time":"17:50:59","subject":"本公司受邀參加元大證券辦理之第二季投資論壇","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-06-02 17:50，「本公司受邀參加元大證券辦理之第二季投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2025-06-02-1636-163x9mm","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2025-06-02","time":"16:36:11","subject":"本公司代子公司思捷優達股份有限公司公告YA-101用於多重系統退化症之日本第二期臨床試驗申請已成功送交PMDA。","clause":"第9款","fact_date":"2025-06-02","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2025-06-02 16:36，「本公司代子公司思捷優達股份有限公司公告YA-101用於多重系統退化症之日本第二期臨床試驗申請已成功送交PMDA。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-06-02-1541-7ui6dp","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-06-02","time":"15:41:10","subject":"本公司受邀參加康和綜合證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-06-02 15:41，「本公司受邀參加康和綜合證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2025-06-02-1531-uutmnv","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2025-06-02","time":"15:31:22","subject":"公告本公司稽核主管異動","clause":"第8款","fact_date":"2025-06-02","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2025-06-02 15:31，「公告本公司稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2025-06-02-1507-aqkmv1","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2025-06-02","time":"15:07:40","subject":"本公司有價證券近期多次達公佈注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2025-06-02 15:07，「本公司有價證券近期多次達公佈注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-06-02-1505-fhdtqg","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-02","time":"15:05:50","subject":"公告本公司董事會決議通過變更營業地址","clause":"第44款","fact_date":"2025-06-02","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-06-02 15:05，「公告本公司董事會決議通過變更營業地址」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-06-02-1504-t6rqxo","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-02","time":"15:04:29","subject":"公告本公司114年股東常會重要決議","clause":"第15款","fact_date":"2025-06-02","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-06-02 15:04，「公告本公司114年股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}